MedPath

Critical Time Intervention in the Transition From Hospital to Community in People With Severe Mental Illness

Not Applicable
Completed
Conditions
Psychotic Disorders
Interventions
Behavioral: Usual care
Behavioral: Critical Time Intervention (CTI)
Registration Number
NCT00621465
Lead Sponsor
New York State Psychiatric Institute
Brief Summary

This study will evaluate the effectiveness of a psychosocial treatment, Critical Time Intervention, in easing the transition from hospital to community in people with severe mental disorders.

Detailed Description

Severe mental illness (SMI) encompasses a wide range of mental disorders and disabilities, but commonly includes disorders that involve symptoms of psychosis. Psychotic symptoms may involve hallucinations, a lost sense of reality, or other distressing symptoms. About 6% of people experiencing psychotic symptoms seek inpatient treatment at a psychiatric hospital. Hospital treatment for a person with SMI often focuses on rapid improvement of negative symptoms and promotion of the necessary skills to successfully return to the community after leaving the hospital. Despite preparation for community integration, the transition from hospital to community remains a difficult time for many people with SMIs, with those affected having an increased chance for suicide, homelessness, and relapse. Critical Time Intervention (CTI), a psychosocial treatment program that aims to restore skills for community living and to assist in seeking service and support in the community, may be more effective than usual care in preventing these adverse outcomes after hospital discharge. This study will compare the effectiveness of CTI versus usual services in preventing homelessness and other adverse outcomes after leaving a psychiatric hospital among people with SMI and psychosis.

Participation in this study will last 18 months. Potential participants will undergo an initial 15- to 30-minute interview that will include questions about current mental, physical, and living conditions; history of psychiatric services; and alcohol and drug use. Eligible participants will then undergo the first full interview, which will include a full review of medical records and will last between 2 and 3 hours. After this interview, participants will be assigned randomly to receive CTI or usual services. For participants assigned to CTI, a CTI specialist will visit participants in the hospital and in their homes and will stay in contact with participants for 9 months after hospital discharge. During visits with the CTI specialist, participants will receive training in community living skills and help finding service and support in the community. Participants assigned to usual services will receive the usual care and community services offered to people recently leaving a psychiatric hospital.

After leaving the hospital, participants in both groups will be asked to participate in 15 follow-up interviews, which will include repeat questions from the 2 initial interviews. Interviews will be conducted once every 6 weeks until 18 months after hospital discharge and will last between 60 and 90 minutes.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
150
Inclusion Criteria
  • Diagnosis of psychosis
  • Homelessness during the 18 months before study entry
  • English speaking
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1Usual careParticipants will receive standard aftercare and community care services.
2Critical Time Intervention (CTI)Participants will receive usual care and the Critical Time Intervention.
2Usual careParticipants will receive usual care and the Critical Time Intervention.
Primary Outcome Measures
NameTimeMethod
Number of adverse outcomes after hospital discharge, particularly homelessnessMeasured over 18 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Rockland Psychiatric Center

🇺🇸

Orangeburg, New York, United States

© Copyright 2025. All Rights Reserved by MedPath